Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ONMD
ONMD logo

ONMD Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.787
Open
0.785
VWAP
0.75
Vol
284.18K
Mkt Cap
38.58M
Low
0.703
Amount
212.94K
EV/EBITDA(TTM)
--
Total Shares
51.01M
EV
37.83M
EV/OCF(TTM)
--
P/S(TTM)
58.65
OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.
Show More

Events Timeline

(ET)
2026-03-18
09:00:00
OneMedNet Announces Strategic Collaboration with Navidence
select
2026-02-27 (ET)
2026-02-27
09:00:00
OneMedNet Launches RWD Platform, Accelerates Subscription Growth
select
2026-02-26 (ET)
2026-02-26
08:50:00
OneMedNet Partners with ViuHealth for Strategic Collaboration
select
2026-02-24 (ET)
2026-02-24
09:00:00
OneMedNet Signs Strategic Data Licensing Agreement with Risorius
select
2026-02-12 (ET)
2026-02-12
09:10:00
OneMedNet CEO Says This Year is a Strategic Inflection Point
select
2026-01-22 (ET)
2026-01-22
09:10:00
OneMedNet Supports mlHealth 360 in Obtaining FDA 510(k) Clearance
select
2026-01-16 (ET)
2026-01-16
09:10:00
OneMedNet Successfully Delivers Data for 1.5 Million Patients
select
2025-12-22 (ET)
2025-12-22
09:10:00
OneMedNet Reduces Liabilities by 75% and Expands Network in 2025
select
2025-12-10 (ET)
2025-12-10
09:00:00
OneMedNet Sees Significant Engagement After RSNA Annual Meeting
select
2025-11-24 (ET)
2025-11-24
08:56:03
OneMedNet to unveil innovative platform at RSNA 2025
select

News

Benzinga
7.5
03-03Benzinga
OneMedNet Shares Decline Amid RWD Platform Growth Strategy Validation
  • Stock Volatility: OneMedNet (NASDAQ:ONMD) shares fell 26.55% on Monday, reflecting market concerns over short-term performance despite the long-term growth potential of its RWD platform.
  • Growth Strategy: The company is actively converting customer evaluations into commercial subscriptions, which are expected to drive predictable growth and millions in annual recurring revenue (ARR), indicating the sustainability of its business model.
  • Platform Integration: OneMedNet has integrated over 2,130 healthcare sites into its iRWD platform powered by Palantir Technologies, accelerating adoption among life sciences and AI health innovators while providing near-real-time access to integrated clinical and longitudinal datasets.
  • Customer Benefits: Life sciences teams and researchers will gain access to comprehensive regulatory-grade multimodal real-world data, with AI-driven search tools enhancing innovation and reducing trial risks, thereby improving research efficiency and evidence generation capabilities.
Benzinga
8.5
02-27Benzinga
OneMedNet Launches Next Phase of Commercial Rollout
  • Platform Launch Progress: OneMedNet announced the next phase of its Real-World Data platform's commercial rollout, powered by Palantir's Foundry technology, leading to an 81.46% surge in stock price, reflecting strong market confidence in its product.
  • Positive Customer Feedback: CEO Aaron Green noted that customer feedback has reinforced the platform's performance, speed, and depth of discovery, which is expected to drive subscription growth, resulting in predictable revenue increases and millions in annual recurring revenue.
  • Data Integration Advantage: With over 2,130 healthcare sites integrated into its iRWD platform, OneMedNet provides real-time access to comprehensive regulatory-grade multimodal data, aiming to accelerate adoption among life sciences and AI health innovators, enhancing customer workflow efficiency.
  • Market Environment Analysis: Despite a weak overall market, OneMedNet's positive news resonates within the healthcare sector, indicating the company's strategic position in the healthcare data landscape, even as its stock remains below its 20-day and 100-day simple moving averages.
Benzinga
4.5
02-27Benzinga
U.S. Stocks Drop Over 600 Points in Morning Trading
  • Market Decline: U.S. stocks traded lower this morning, with the Dow Jones index falling over 600 points on Friday, a 1.25% drop to 48,879.67, indicating weakened market sentiment.
  • Tech Sector Drop: Information technology stocks fell by 1.8% during Friday's trading, reflecting investor concerns about the sector's outlook, which may impact future investment decisions.
  • Producer Prices Rise: U.S. producer prices increased by 0.5% month-over-month in January, surpassing market expectations of 0.3% and the revised 0.4% gain in December, indicating persistent inflationary pressures that could influence Federal Reserve policy.
  • Commodity Market Fluctuations: Oil prices rose by 3.5% to $67.51, while gold increased by 1% to $5,243.90, suggesting that investors are turning to commodities for safety amid an uncertain stock market environment.
PRnewswire
8.5
01-27PRnewswire
Rapid Growth in Cardiac AI Diagnostics Market
  • Market Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-native precision, particularly due to the rising demand for heart monitoring in cancer treatments.
  • Rise of Cardiac AI Diagnostics: The cardiac AI diagnostics sector hit $2.22 billion in 2026, driven by the urgent need for continuous imaging to monitor heart dysfunction, enhancing the company's competitive edge in the medical technology market.
  • Strategic Partnership Enhances Value: Ventripoint's collaboration with Summit Sciences to develop ROI models illustrates how hospitals can achieve cost savings through technological improvements, further solidifying its market position in cardiac care.
  • Executive Appointment Fuels Growth: The appointment of David Swetlow as CFO, with extensive experience in medical technology, is expected to accelerate market adoption and revenue growth, driving the execution of the company's commercial strategy.
Newsfilter
8.5
01-27Newsfilter
Rapid Growth in Cardiac AI Diagnostics Market
  • Market Size Surge: The global medical imaging market reached $45.5 billion in 2026, indicating a significant shift towards AI-driven precision, with the cardiac AI diagnostics sector hitting $2.22 billion, reflecting a critical demand for continuous imaging.
  • Technological Innovation: VentriPoint Diagnostics is transforming standard 2D ultrasound images into MRI-level 3D heart models, significantly reducing costs and complexity, which is expected to drive rapid growth in its subscription business.
  • Surge in Investment Demand: The company recently doubled its private placement from $500,000 to $1 million, with funds allocated for commercialization and market expansion, showcasing strong investor confidence in its technology and market potential.
  • Strategic Partnership: VentriPoint's collaboration with Summit Sciences to develop ROI models aims to demonstrate the economic value of its technology to hospitals, further solidifying its market position in medical imaging.
NASDAQ.COM
8.5
01-22NASDAQ.COM
OneMedNet (ONMD) Aids mlHealth in FDA Approval of AI BrainCT Software
  • FDA Approval Milestone: OneMedNet partnered with mlHealth 360 to secure FDA clearance for Scaida BrainCT-ICH, an AI software that detects intracranial hemorrhage from head CT scans in approximately 5.97 seconds, significantly enhancing clinical decision-making in acute care.
  • Critical Data Support: OneMedNet's regulatory-grade Real-World Data, encompassing electronic medical records, diagnostic imaging, and clinical reports, played a pivotal role in model development, validation, and regulatory submission, underscoring the importance of high-quality data in accelerating innovation.
  • Market Performance Review: Over the past year, ONMD's stock traded between $0.30 and $4.22, with a nearly 7% increase to $0.92, reflecting market recognition of its innovative capabilities.
  • CEO Insights: OneMedNet's CEO Aaron Green stated that seeing the company's Real-World Data directly contribute to an FDA-cleared solution reinforces the value of high-quality data in driving meaningful innovation.

Valuation Metrics

The current forward P/E ratio for Onemednet Corp (ONMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Onemednet Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks which can short term gains under 1 $
Intellectia · 29 candidates
Price: $0.10 - $1.00Volume: >= 1,000,000Rsi Category: moderateRelative Vol: >= 1.50Week Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGL logo
AGL
agilon health inc
244.48M
ENSC logo
ENSC
Ensysce Biosciences Inc
2.26M
AERT logo
AERT
Aeries Technology Inc
21.59M
AIIO logo
AIIO
Robo.ai Inc
62.03M
SKYQ logo
SKYQ
Sky Quarry Inc
12.74M
UPXI logo
UPXI
Upexi Inc
61.39M
swing trades under 3 dollars
Intellectia · 97 candidates
Price: $0.50 - $3.00Volume: >= 500,000Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $0.00 - $50.00Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
ZBAO logo
ZBAO
Zhibao Technology Inc
34.27M
SKYQ logo
SKYQ
Sky Quarry Inc
12.74M
MGN logo
MGN
Megan Holdings Ltd
89.91M
RCON logo
RCON
Recon Technology Ltd
52.68M
AURE logo
AURE
Aurelion Inc
84.32M
VEEA logo
VEEA
Veea Inc
28.09M
stocks with in 5$ surging high
Intellectia · 9 candidates
Price: $1.00 - $5.00Volume: >= 1,000,000Price Change Pct: >= $10.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
ONMD logo
ONMD
Onemednet Corp
52.03M
EDSA logo
EDSA
Edesa Biotech Inc
18.37M
ALBT logo
ALBT
Avalon Globocare Corp
8.58M
HUBC logo
HUBC
Hub Cyber Security Ltd
3.23M
PMVP logo
PMVP
PMV Pharmaceuticals Inc
90.46M
RC logo
RC
Ready Capital Corp
299.93M

Whales Holding ONMD

D
Discovery Capital Management, LLC
Holding
ONMD
-9.47%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Onemednet Corp (ONMD) stock price today?

The current price of ONMD is 0.7564 USD — it has decreased -4.9

What is Onemednet Corp (ONMD)'s business?

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.

What is the price predicton of ONMD Stock?

Wall Street analysts forecast ONMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ONMD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Onemednet Corp (ONMD)'s revenue for the last quarter?

Onemednet Corp revenue for the last quarter amounts to 177.00K USD, increased 24.65

What is Onemednet Corp (ONMD)'s earnings per share (EPS) for the last quarter?

Onemednet Corp. EPS for the last quarter amounts to -0.01 USD, decreased -85.71

How many employees does Onemednet Corp (ONMD). have?

Onemednet Corp (ONMD) has 22 emplpoyees as of March 23 2026.

What is Onemednet Corp (ONMD) market cap?

Today ONMD has the market capitalization of 38.58M USD.